Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit
- PMID: 26193780
- DOI: 10.1016/j.jcrc.2015.06.020
Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit
Abstract
Purpose: The prognosis of allogeneic hematopoietic stem cell transplantation (HSCT) patients admitted to the intensive care unit (ICU) is still poor. Overall, when these patients receive reduced intensity conditioning (RIC) regimens, the survival is better. To date, no study has specifically evaluated the outcome of RIC allogeneic HSCT admitted to the ICU.
Methods: We realized a retrospective study of 102 patients admitted to the ICU among a cohort of 601 consecutive patients receiving RIC regimens. The primary objective of the study was to assess in-ICU and inhospital mortality rates.
Results: The ICU mortality was 39.2%, and the hospital mortality was 59.8%. The median overall survival of ICU patients was 8.2 months (95% confidence interval [CI], 5.7-10.6) vs 75 (95% CI, 63-87) in non-ICU patients (P < .0001). During hospital stay, an ICU admission for neurologic dysfunction was independently associated with hospital survival (P = .012). The use of invasive mechanical ventilation (IMV; P = .011), Simplified Acute Physiology Score II (P = .003), and longer time between diagnosis of malignancy and HSCT (P = .012) were associated with hospital mortality. The overall survival of the ICU survivors was significantly lower than that of non-ICU patients (hazard ratio, 3.61 [95% CI, 2.18-4.59]; P < .001). The median survival of ICU survivors was 9 months (95% CI, 4-14) vs 75 (95% CI, 63-87) in non-ICU patients (P < .0001). Noninvasive ventilation (NIV) was successful (not followed by IMV in 61% of cases [25/41 NIV patients]), and failure of NIV was not associated with hospital mortality in patients treated with subsequent IMV.
Conclusion: From our study, short-term survival rates of ICU patients receiving RIC regimens justify a broad ICU admission policy. The use of IMV is associated with hospital mortality, whereas the use of NIV is frequently successful. Long-term outcome remains poor after ICU discharge.
Keywords: Allogeneic hematopoietic stem cell transplantation; Hematology patients; Intensive care unit; Mechanical ventilation; Prognosis; Reduced-intensity conditioning regimen.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Risk factors of non-invasive ventilation failure in hematopoietic stem-cell transplantation patients with acute respiratory distress syndrome.Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620914220. doi: 10.1177/1753466620914220. Ther Adv Respir Dis. 2020. PMID: 32345137 Free PMC article.
-
Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.Br J Anaesth. 2012 Mar;108(3):452-9. doi: 10.1093/bja/aer449. Epub 2012 Jan 31. Br J Anaesth. 2012. PMID: 22298243 Review.
-
Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.Eur J Haematol. 2005 Feb;74(2):144-51. doi: 10.1111/j.1600-0609.2004.00360.x. Eur J Haematol. 2005. PMID: 15654906
-
Short- and long-term outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis.Oncotarget. 2016 Apr 19;7(16):22427-38. doi: 10.18632/oncotarget.7986. Oncotarget. 2016. PMID: 26968953 Free PMC article.
-
Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.Bone Marrow Transplant. 2016 Aug;51(8):1050-61. doi: 10.1038/bmt.2016.72. Epub 2016 Apr 4. Bone Marrow Transplant. 2016. PMID: 27042832 Review.
Cited by
-
Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period.Leuk Lymphoma. 2017 Feb;58(2):382-390. doi: 10.1080/10428194.2016.1195499. Epub 2016 Jun 27. Leuk Lymphoma. 2017. PMID: 27347608 Free PMC article.
-
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients.Ann Hematol. 2024 Mar;103(3):957-967. doi: 10.1007/s00277-023-05612-9. Epub 2024 Jan 3. Ann Hematol. 2024. PMID: 38170240 Free PMC article.
-
Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores.Cancers (Basel). 2022 Aug 31;14(17):4266. doi: 10.3390/cancers14174266. Cancers (Basel). 2022. PMID: 36077800 Free PMC article.
-
Prognostic factors of pediatric hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit.Acute Crit Care. 2021 Nov;36(4):380-387. doi: 10.4266/acc.2020.01193. Epub 2021 Nov 26. Acute Crit Care. 2021. PMID: 34736299 Free PMC article.
-
Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study.Ann Hematol. 2021 Nov;100(11):2787-2797. doi: 10.1007/s00277-021-04640-7. Epub 2021 Sep 3. Ann Hematol. 2021. PMID: 34476574
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources